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ABSTRACT
Objectives: This study aimed to investigate placental expression of AChE, α7nAChR and NF-κB in patients with preeclampsia 
and discuss about its clinical significance.
Material and methods: mRNA expression levels of acetylcholine (AChE), alpha-7 nicotinic acetylcholine receptor (α7nAChR) 
and nuclear factor-kB (NF-κB) in placenta were detected by qRT-PCR, and protein levels were determined by immunohis-
tological analysis and Western Blot in 35 women with preeclampsia (including 20 cases of mild preeclampsia and 15 cases 
of severe preeclampsia) and 30 cases in control group, respectively. 
Results: The expression of AChE mRNA and protein in placenta increased significantly in patients with preeclampsia 
compared with the control group (p < 0.01). It was lower in patients with severe preeclampsia than in patients with mild 
preeclampsia (p < 0.05). The expression of α7nAChR mRNA and protein in placenta decreased significantly in patients with 
preeclampsia compared with the control group (p < 0.01). However, the expression of α7nAChR mRNA and protein in patients 
with severe preeclampsia was higher than that in patients with mild preeclampsia, without significant difference (p > 0.05).  
The expression of NF-κB protein in placenta decreased significantly in patients with preeclampsia compared with the control 
group (p < 0.01). It was higher in patients with severe preeclampsia than in patients with mild preeclampsia (p < 0.05), but 
there was no significant difference between preeclampsia group and control group in the expression of NF-κB mRNA in 
placenta (p > 0.05). The results of Western blotting assay were consistent with those of immunohistochemistry. 
Conclusions: Abnormal expression of AChE, α7nAChR and NF-κB in placenta may be associated with preeclampsia. Cho-
linergic anti-inflammatory pathway may play an important role in the pathogenesis of preeclampsia.
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INTRODUCTION
Preeclampsia (PE) is a specific and common disease 
during pregnancy and poses great threat to the health of 
the mother and infant [1]. The pathogenesis of PE remains 
unclear. It is generally believed that PE is a systemic inflam-
matory response of the mother, presenting as inflamma-
tory response in the maternal-fetal interface, activation of 
inflammatory cells and dysfunction and injury of vascular 
endothelial cells. Cholinergic anti-inflammatory pathway 
has attracted increasing attention in recent years. Nervous 
system has intrinsic connections with the immune system, 
with the former regulating the immune response and con-
trolling the inflammatory response [2–4]. It has been shown 
that acetylcholine (ACh) levels increase in PE patients during 
late pregnancy compared with normal pregnant women. It 
is inferred that cholinergic anti-inflammatory pathway may 
be associated with the pathogenesis of PE [5]. But what 
a specific role cholinergic anti-inflammatory pathway plays 
in this process is largely unknown. This study determined the 
expression of acetylcholinesterase (AChE), alpha-7 nicotinic 
acetylcholine receptor (α7nAChR) and nuclear factor-kB 
(NF-kB) in the placenta of PE patients and normal pregnant 
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women, and discussed about its clinical implications. The 
relationship between cholinergic anti-inflammatory path-
way and PE was investigated. The findings shed new light on 
the pathogenesis of PE and the prevention and treatment 
strategies. 
MATERIAL AND METHODS
Thirty-five PE patients who gave birth at department 
of obstetrics and gynecology of Hainan Provincial People’s 
Hospital from January 2013 to January 2014 were inclu-
ded. PE was diagnosed and classified according to Obste-
trics and Gynaecology (8th Version) edited by Xin Xie [6]. Mild 
PE was defined as new onset of both hypertension (blood 
pressure ≥ 140/90 mm Hg) and proteinuria [≥ 300 mg/24 ho-
urs urine collection or random urine protein (+)] after 20 we-
eks of gestation. Indicators of severity of preeclampsia were 
blood pressure ≥ 160/110 mm Hg, plus severe proteinuria 
(5.0 g/24 h or greater than 2+ by dipstick) and clinical or 
laboratory findings indicative of organ dysfunction. There 
were 20 cases with mild PE and 15 cases with severe PE. 
Among the cases, there were 10 women (8 with severe and 
2 with mild preeclampsia) with early onset preeclampsia 
(before 34 weeks gestation) and 25 cases (7 with severe and 
18 with mild preeclampsia) with late-onset preeclampsia 
(after 34 weeks gestation). The gestation-matched placentas 
of normal pregnancy were chosen as normal control with no 
history of hypertension or proteinuria during 35–40 weeks 
of pregnancy who delivered healthy neonates via cesa-
rean section. The baseline blood pressure in the control 
group was 121.6 ± 0.6/78 ± 0.8 mm Hg. None of the cases 
had other obstetric, internal medicine and surgical compli-
cations. This study was approved by the ethics committees 
of Hainan People’s Hospital (Haikou, China). Written consent 
was obtained from each patient.
Sample collection
Placental tissues were collected within 5min after de-
livery of placenta. A block of placental tissues of about 
3 cm × 3 cm × 3 cm was taken at the center of the maternal 
side of the placenta away from the calcified region. The 
sample was washed with normal saline, fixed in 10% neutral 
formalin and made into paraffin-embedded sections. 
Immunohistochemical detection of AChE, 
α7nAChR and NF-κB protein in the placenta
Paraffin-embedded sections (3–4 μm thick) were depa-
raffinized in xylene three times (10 min each at room tem-
perature) and rehydrated through a gradient of ethanol. An-
tigen retrieval was performed with microwave treatment in 
0.01 M citrate buffer for 30 min. After quenching endogenous 
peroxidase activity and blocking with normal goat serum, 
sections were incubated with primary antibodies against 
human α7nAChR (1:100; ProteinTech Group, Inc.Chicago, 
USA), AChE and NF-κB (1:200, Biotechnology Inc, CA, USA) 
for 1 h. Washed sections were incubated for 10min with secon-
dary goat anti-rabbit IgG biotin. The slides were then rinsed 
with PBS-Tween-20 (three times, 3 min each), and visualized 
with DAB chromogenic agent. Sections were counterstained 
with hematoxylin and then observed with a microscope sys-
tem (Olympus LX70; Olympus, Middlesex, UK). The sections 
were sealed with neutral balsam. Appearance of pale brown 
and brown particles in the nuclei and cytoplasm indicated 
positive expression of AChE, α7nAChR and NF-κB. Different 
percentages of positive cells were given different scores: 
0 — 5%; 1 — 5–20%; 2 — 20–50%; 3 — 50–75%; 4 — 75%. 
Different staining intensity was also given different scores: 
0 — no staining; 1 — light yellow; 2 — yellow; 3 — deep 
yellow. The two scores were multiplied together. A final score 
of ≤ 4 was assigned to the negative expression group, while 
a final score of ≥ 5 was assigned to the positive expression 
group. Two senior pathologists determined the scores 
Detection of AChE, α7nAChR and NF-κB 
expression in placenta using Western Blot
The placenta sample was weighed and crushed 
in a mortar. Protein sample was collected. Total protein 
extraction from the placenta was performed according to 
kit instructions. Coomassie R-250 was used to stain protein 
gels (Bradford assay). Proteins were resolved by SDS-PAGE 
and transferred to nitrocellulose membranes. Thereafter, 
the primary antibodies including AChE (diluted at 1:400; 
Beyotime Biotechnology), α7nAChR (diluted at 1:400; Bey-
otime Biotechnology), NF-κB (diluted at 1:400; Beyotime 
Biotechnology) and β-actin (diluted at 1:1,000, Abcam) were 
dissolved in TBST and used to incubate membranes at 4°C 
overnight. After a cleaning in TBST, membranes were in-
cubated with the appropriate HRP-conjugated secondary 
antibody (diluted at 1:2000; Beyotime Biotechnology) for 
2 hours at room temperature. The membrane was air dried 
and photographed using a gel imaging system. The results 
were analyzed using Quality One software. The relative 
expression of the target band was calculated based on the 
optical density ratio of target band to β-actin. 
qRT-PCR detection of AChE, α7nAChR  
and NF-κB mRNA expression
The qRT-PCR was performed on a 7500 fast Real Time 
PCR system (Applied Biosystems, USA) with a final volume of 
20 μL per reaction. Total RNA was isolated from the placental 
tissue with TRIzol reagent (Invitrogen). cDNA was synthesi-
zed from total RNA using RevertaidTM First Strand cDNA 
Synthesis Kit (Thermo, USA), according to the manufacturer’s 
instructions. Each 20 μL reaction mixture contained 2 μL of 
diluted cDNA, 10 μL of TaqMan® Universal PCR Master Mix 
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(Applied Biosystems, USA) 1 μL of each primer, and 7 μL of 
sterile distilled water. The thermal cycling program was 95° 
C for 30 s, followed by 40 cycles of 95° C for 5 s, 60° C for 30 s, 
and 72° C for 15 s. Melt-curve analyses were performed using 
a program with constant heating from 70° C to 95° C, follo-
wed by 95° C for 15 s. Each reaction was carried out for three 
technical replicates. The sequences of the qRT-PCR primers 
used in this study were designed and synthesized by Sangon 
Biotech Co., Ltd (Sanghai, China) and listed in Table 1. The 
qRT-PCR data were analyzed using the ΔΔCt method.
Statistical method 
Statistical analysis was conducted using SPSS 21.0 so-
ftware. Comparisons of multiple groups were performed 
using one-way analysis of variance (ANOVA), followed by the 
least significant difference (LSD) post hoc test or Dunnett’s 
test as appropriate. When homogeneity test of variance was 
neat, an appropriate LSD post hoc test was employed. Also, 
Chi-square test was used for data analysis. Data are expres-
sed as the mean ± standard deviation (SD). P < 0.05 indicated 
significant difference. Assays were performed at least three 
times independently.
RESULTS
Immunohistochemical detection of AChE, 
α7nAChR and NF-κB in placenta 
The rate of strongly positive expression of AChE was 
45.0% (9/20) in the mild PE group and 33.3% (5/15) in the 
severe PE group. Both rats were lower compared with 73.3% 
(22/30) in the normal group. There was significant difference 
between PE group (mild and severe group) and control 
group. The rate of strongly positive expression of α7nAChR 
was 65.0% (13/20) in the mild PE group and 53.3% (8/15) in 
the severe PE group. Both rats were higher compared with 
20.0% (6/30) in the normal group. There was significant 
difference between PE group (mild and severe group) and 
control group. The rate of strongly positive expression of 
NF-κB was 75.0% (15/20) in the mild PE group and 86.7% 
(13/15) in the severe PE group. Both rats were higher com-
pared with 26.7% (8/30) in the normal group. There was 
significant difference between PE group (mild and severe 
group) and control group (Fig. 1 and Tab. 2).
Expression levels of AChE, α7nAChR and NF-κB protein 
in the placenta were detected by Western Blot, with the 
results shown in Figure 2 and Table 3.
Table 1. Detail information on the selection of primers for real-time RT-PCR experiments
Name Primers sequence (sense) Primers sequence (antisense)
AChE 5’-TAC TTC TCC CAC ACC TGT CCT CA-3’ 5’-ATA GAT ACC AAC ACG GTT CCC TC-3’
α7nAChR 5’-GGT CGT ATG TGG CCG TTT G-3’ 5’-TGC GGT TGG CGA TGT AGC G-3’
NF-κB 5’-CAC AGA TAC CAC TAA GAC GCA CC-3’ 5’-GAC CGC ATT CAA GTC ATA GTC C-3’
β-actin 5’-CCC ATC TAT GAG GGT TAC GC-3’ 5’-TTT AAT GTC ACG CAC GAT TTC-3’
AChe
α7nAChR
NF-κB
Control
group
Mild
group
Severe
group
Figure 1. Expression of AChE, α7nAChR and NF-κB in placenta: Immunohistochemistry analysis of AChE, α7nAChR and NF-κB from placenta in 
preeclampsia (including mild preeclampsia and severe preeclampsia) or control group. (SP, × 400)
252
Ginekologia Polska 2018, vol. 89, no. 5
www. journals.viamedica.pl/ginekologia_polska
The AChE expression in the placenta of PE patients was 
significantly lower compared with the normal pregnant 
women (p < 0.01). Moreover, the AChE expression was lower 
in the severe PE cases than in the mild PE cases (p < 0.05). 
The α7nAChR expression in the placenta of PE patients was 
significantly higher compared with the normal pregnant 
women (p < 0.01). Moreover, the α7nAChR expression was 
lower in the severe PE cases than in the mild PE cases, but 
without significant difference. The NF-κB expression in the 
placenta of PE patients was significantly higher than that 
in the normal pregnant women (p < 0.01). Moreover, the 
NF-κB expression was considerably higher in the severe PE 
cases than in the mild PE cases (p < 0.05).
Changes in mRNA expression levels of AChE, α7nAChR 
and NF-κB in the placenta are shown in Figure 3 and Table 4. 
The mRNA expression of AChE in PE patients was signi-
ficantly lower compared with the normal pregnant women 
(p < 0.01). Moreover, the expression was considerably lower 
in severe PE cases than in mild PE cases (p < 0.05). The mRNA 
expression of α7nAChR in PE patients was significantly higher 
AChE α7nAChR
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
NF-κB
Control Mild Severe
Relative proteins expression
AChe
α7nAChR
NF-κB
β-actin
Control
group
Mild
group
Severe
group
**
**
#
#
**
**
**
**
Figure 2. Expression of AChE, α7nAChR and NF-κB protein in placental tissues of pregnant women with preeclampsia (including mild preeclampsia 
and severe preeclampsia) and normal tissues detected by Western blot 
*p < 0.05 vs. control; **p < 0.01 vs. control; #p < 0.01 vs. mild; ##p < 0.05 vs. mild
Table 2. Differential expression of AChE, α7nAChR and NF-κB in distinct histological placental tissue 
Group n
AChE α7nAChR NF-κB
– + – + – +
Control 30 8 22 24 6 22 8
Mild 20 11 9 7 13 5 15
Severe 15 10 5 7 8 2 13
χ2值
4.09 a 10.31 a 11.29 a
6.67 b 5.18 b 14.46 b
P值
< 0.05 a < 0.01 a < 0.01 a
< 0.05 b < 0.05 b < 0.01 b
avs. mild; bvs. severe; (+) — positive; (–) — negative
Table 3. Comparison of protein expressions of AChE, α7nAChR and NF-κB in placental tissues
Group AChE α7nAChR NF-κB
Control group 0.63 ± 0.09 0.55 ± 0.06 0.43 ± 0.04
Mild group 0.51 ± 0.06** 0.73 ± 0.06** 0.64 ± 0.05**
Severe group 0.43 ± 0.04**/# 0.69 ± 0.04** 0.73 ± 0.06**/#
F 31.00 56.38 177.90
*p < 0.05 vs. control; **p < 0.01 vs. control, #p < 0.05 vs. mild, ##p < 0.01 vs. mild
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compared with the normal pregnant women (p < 0.01). Mo-
reover, the expression was considerably reduced in severe PE 
cases than in mild PE cases, but without significant difference 
(p > 0.05). The two groups showed no significant difference 
in mRNA expression of NF-κB (p > 0.05). 
DISCUSSION
Preeclampsia (PE) usually affects multiple systems du-
ring pregnancy, causing death of mothers and perinatal 
infants [7]. Recent study has shown that excess inflammatory 
response to pregnancy in PE can cause immune imbalance 
in maternal-fetal interface, placental vascular lesions, va-
scular endothelial injury, limited migration of trophocytes 
and shallow placental implantation [8]. PE is associated with 
an upregulation of proinflammatory cytokines and chemo-
kines [9]. Many scholars believe that inflammatory response 
plays an important role in pathological processes of PE and 
IUGR and HELLP syndrome. Excess inflammatory response 
is harmful to the organisms, which in turn produce complex 
compensatory anti-inflammatory response.
In 2000 Borovikova et al. [10] proposed the concept of 
cholinergic anti-inflammatory pathway as a possible neural 
anti-inflammatory mechanism. Specifically, the brain reco-
gnizes the signals transmitted by the afferent vagus nerve, 
which stimulates the release of ACh by the vagus nerve 
endings. ACh then binds to the α7nAChR on the surface 
of macrophages and other types of cells, inhibiting the 
synthesis and release of inflammatory cytokines, including 
tumor necrosis factor (TNF), interleukin (IL) –1 and high-
-mobility group box 1 (HMGB1), and hence suppressing the 
anti-inflammatory effect [11, 12]. In 1986 Satyanarayana [13] 
reported a significant reduction in the synthesis of ACh in 
syncytiotrophoblasts with moderate generation (e.g., PE, 
eclampsia and intrauterine death). Murthy et al. [14] also 
reported similar reduction of ACh release in the placenta 
of PE patients. Our preliminary study indicated variability 
of the expression of cholinesterase (ChE) and cytokines in 
PE of different severity [5]. From this we inferred that the 
cholinergic anti-inflammatory pathway may play a role in it.
AChE is a key enzyme in biological nerve conduction 
that can degrade ACh, terminate the excitation of the post-
synaptic membrane caused by neurotransmitters and ensu-
re the normal transmission of nerve impulses. AChE is an im-
portant regulatory factor in cholinergic transmission. Some 
mechanisms must work to regulate the activity of AChE to 
ensure the normal functioning of ACh. Study has shown that 
serum AChE activity decreased in severe trauma, burn injury 
and sepsis [15, 16]. Cholinergic anti-inflammatory pathway 
that regulates neural and immune system may play a role 
by downregulating AChE to generate the compensatory 
anti-inflammatory response, thus promoting further release 
of ACh by vagus nerve. Our results indicated that the mRNA 
and protein expression levels of AChE in the placenta of PE 
patients were considerably lower compared with the normal 
pregnant women. In addition, the expression levels were 
significantly lower in severe PE than in mild PE. However, it 
remains unclear whether the decreased AChE activity was 
caused by activation of the cholinergic anti-inflammatory 
pathway or by liver injury associated with PE. 
Accumulating evidence has pointed out that a7nAChR 
plays an essential role in Cholinergic anti-inflammatory 
pathway [17, 18]. In vitro study has shown that α7nAChR 
is most highly expressed in human umbilical vein endo-
thelial cells (HUVECs) and microvascular endothelial cells. 
Table 4. Comparison of mRNA expressions of AChE, α7nAChR and NF-κB in placental tissues
Group AChE α7nAChR NF-κB
Control group 1.55 ± 0.12 1.68 ± 0.19 1.87 ± 0.20
Mild group 0.96 ± 0.11** 2.04 ± 0.33** 1.95 ± 0.25
Severe group 0.64 ± 0.09**/# 1.92 ± 0.15** 2.02 ± 0.22
F 28.9 13.28 1.75
*p < 0.05 vs. control, **p < 0.01 vs. control, #p < 0.05 vs. mild, ##p < 0.01 vs. mild
AChE α7nAChR
2.5
2
1.5
1
0.5
0
NF-κB
Control Mild Severe
Relative mRNA expression
**
**
#
**
**
Figure 3. Expression of AChE, α7nAChR and NF-κB mRNA in placental 
tissues of pregnant women with preeclampsia (including mild 
preeclampsia and severe preeclampsia) and normal tissues detected 
by qRT-PCR 
*p < 0.05 vs. control; **p < 0.01 vs. control; #p < 0.05 vs. mild; ##p < 0.01 
vs. mild
254
Ginekologia Polska 2018, vol. 89, no. 5
www. journals.viamedica.pl/ginekologia_polska
Hypoxia and nicotine can cause a significant upregulation 
of α7nAChR in HUVECs [19]. However, contradictory results 
have been reported as well, which found a downregulation 
of α7nAChR under hypoxia [20, 21]. Our results showed that 
α7nAChR was expressed in the placenta of both normal 
pregnant women and PE patients. The expression in PE 
patients was much higher than that in the control group, 
and it was reduced in severe PE compared with mild PE. 
qRT-PCR confirmed the above findings. Thus, it was inferred 
that ACh-bound α7nAChR may play a role in the pathoge-
nesis of PE. However, the divergence from the result by Rita 
Machaalani et al. may be due to the variation in severity 
and duration of hypoxia exposure in PE, patients’ age and 
number of patients [22, 23]. 
Activation of NF-κB nuclear translocation is a key ele-
ment to upregulate many inflammatory mediators such 
as TNF-α, IL-6 and IL-1β. There is increasing evidence that 
cholinergic stimulation can inhibit cytokines by inhibiting 
the NF-kB pathway through an a7nAChR-dependent anti-
-inflammatory pathway [24, 25]. An early study showed 
that the plasma from pregnant women with hypertension 
could activate NF-κB and the activity of NF-κB was increased 
by 2.5 times compared with the normal pregnant women 
[26]. In our study, qRT-PCR was performed to detect NF-κB 
in the placenta of PE patients. The results indicated no si-
gnificant difference in mRNA expression of NF-κB between 
PE patients and normal pregnant women. Immunohisto-
chemistry indicated a stronger staining of NF-κB in the 
placenta of PE patients than in normal pregnant women. 
Moreover, the NF-κB expression in the placenta of severe 
PE patients was higher than that in mild PE patients. These 
results implied the pathological role of NF-κB in PE, whose 
expression intensity reflects the severity of PE. This agrees 
with the findings in many other studies [27–29]. The pa-
thogenesis of PE may be related to the activation of NF-κB, 
which in turn participates in microvascular wall remodeling 
and placental vascular inflammation. Interestingly, our study 
found no significant difference in mRNA expression of NF-κB 
in the placenta between PE patients and normal pregnant 
women. It can be inferred that the anti-inflammatory target 
of ACh is the protein. The discordance between transcript 
and protein expression levels may be due to differential 
rates of transcription and translation and/or in vivo and 
post mortem degradation rates of transcripts and proteins 
[30–32]. While the stability of transcripts and proteins vary 
according to their functional characteristics [33, 34], the 
rate of translation has been found to be the most important 
factor in predicting protein expression [35]. 
The present study showed that in mild PE cholinergic anti-
-inflammatory pathway can be activated as a compensatory 
response by inhibiting the nuclear factor-kB pathway through 
an a7nAChR-dependent pathway. However, the above pro-
cesses induce abnormalities of the cholinergic anti-inflam-
matory pathway in severe PE. As AChE activity decreases and 
less ACh is synthesized and released, α7nAChR expression will 
decrease or even become zero. In contrast, as NF-κB release 
increases, a large number of toxic factors such as inflamma-
tory mediators will be released, leading to vascular stenosis 
and disorder of placental vascular remodeling. 
In conclusion, we found that AChE, α7nAChR and NF-κB 
were involved in the pathophysiology of preeclampsia. The 
results demonstrate that α7nAChR-mediated CAP is a neu-
ro-physiological mechanism and its disruption may be due 
to the impairment of placental function in preeclampsia. 
Further, these results imply that targeting α7nAChR may 
be a promising interventional strategy for preeclampsia.
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